Intelligent Insulin Delivery System with AI, IoT, and Blockchain Integration

A novel insulin delivery system that combines AI-powered glucose level prediction, IoT-enabled insulin delivery, and blockchain-based secure data storage to provide personalized and optimized insulin delivery rates for diabetes patients.

The original patent, 'Adjusting insulin delivery rates,' has limitations in terms of accuracy and security. The new inventive concept addresses these limitations by integrating AI, IoT, and blockchain technologies to provide a more accurate, secure, and transparent insulin delivery system.

The system comprises a glucose measurement device, a processor, a communication module, and an insulin delivery module. The processor uses AI algorithms to predict multiple future blood glucose levels for multiple different basal insulin delivery profiles. The communication module transmits the predicted future blood glucose levels to a blockchain network, which verifies and securely stores the data. The insulin delivery module adjusts the basal insulin delivery rate based on the predicted future blood glucose levels. The system can also integrate with IoT devices to provide real-time monitoring and adjustments.

The new inventive concept is novel and non-obvious due to the integration of AI, IoT, and blockchain technologies, which provides a secure, transparent, and personalized insulin delivery system. The use of AI algorithms to predict future blood glucose levels and the integration with blockchain and IoT devices are significant advancements over the original patent.

Alternative embodiments of the inventive concept could include using different AI algorithms, such as neural networks or machine learning, to predict future blood glucose levels. The system could also be integrated with other technologies, such as wearables or mobile devices, to provide additional data and functionality.

The inventive concept has significant commercial potential in the diabetes management market, with potential applications in hospitals, clinics, and home care settings. The system could be marketed as a premium product, offering advanced features and functionality to diabetes patients and healthcare providers.